The biochemistry of gene therapy for AIDS.
Gene therapy has enormous potential and could in the near future involve the clinical biochemist in monitoring its efficacy. The involvement of clinical biochemists in this field could be not only in evaluating the impact of a gene-based strategy on disease progression, but also in measuring the expression of the products of therapeutic genes in treated individuals. Indeed, gene therapy presents new possibilities for the treatment of many diseases and, in particular, merits consideration in the treatment of a fatal disease like AIDS. The aim of this paper is to review the biochemical basis and clinical relevance of the gene therapy approaches directed towards the inhibition of human immunodeficiency virus type-1. We discuss the goals which have been achieved, the problems which have occurred and the efforts that are being made to solve them. In this regard, particular attention is paid to new strategies targeting 'therapeutic' enzymes to human immunodeficiency virus type-1 nucleic acids.
Savarino
A
A
Dipartimento di Scienze Medico-Chirurgiche, Sezione di Malattie Infettive, Torino, Italy.
Pescarmona
G P
GP
Turco
E
E
Gupta
P
P
D000163:Acquired Immunodeficiency Syndrome / Q000628:therapy* / Q000821:virology; D001669:Biochemical Phenomena; D001671:Biochemistry; D002986:Clinical Trials as Topic; D015316:Genetic Therapy / Q000379:methods*; D015497:HIV-1 / Q000235:genetics / Q000276:immunology / Q000502:physiology; D006801:Humans; D007114:Immunization; D016372:RNA, Antisense / Q000235:genetics / Q000627:therapeutic use; D014779:Virus Replication
D016372:RNA, Antisense